Harrow Health(HROW) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Harrow Announces Third Quarter 2024 Financial Results Third Quarter 2024 and Recent Selected Highlights: ● Revenues increased 44% from $34.3 million in the prior-year quarter to $49.3 million ● GAAP net loss of $(4.2) million ● Adjusted EBITDA of $8.8 million ● Operating cash flow of $3 million ● Cash and cash equivalents of $72.6 million as of September 30, 2024 ● VEVYEtotal prescriptions up 55% over the second quarter of 2024 ● IHEEZO® customer unit demand volume up 15% over the second quarte ...